Study: Tirzepatide Results in Weight Loss for Individuals With Type 1 Diabetes
Pharmacy Times,
Tirzepatide (Zepbound; Lilly) resulted in an average of 18.5% weight loss and improved glucose control in patients with type 1…
Tirzepatide (Zepbound; Lilly) resulted in an average of 18.5% weight loss and improved glucose control in patients with type 1…
A new study published in the journal Diabetes Technology
Tirzepatide facilitates weight loss in obese people with type 2 diabetes and therefore improves glucose control and also…
A new study published in the journal Diabetes Technology